BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 38494878)

  • 21. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.
    Johnson P; Zhou Q; Dao DY; Lo YMD
    Nat Rev Gastroenterol Hepatol; 2022 Oct; 19(10):670-681. PubMed ID: 35676420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis.
    Zhong F; Liu S; Hu D; Chen L
    J Cancer; 2022; 13(3):1048-1060. PubMed ID: 35154469
    [No Abstract]   [Full Text] [Related]  

  • 23. Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma.
    Unfried JP; Marín-Baquero M; Rivera-Calzada Á; Razquin N; Martín-Cuevas EM; de Bragança S; Aicart-Ramos C; McCoy C; Prats-Mari L; Arribas-Bosacoma R; Lee L; Caruso S; Zucman-Rossi J; Sangro B; Williams G; Moreno-Herrero F; Llorca O; Lees-Miller SP; Fortes P
    Cancer Res; 2021 Oct; 81(19):4910-4925. PubMed ID: 34321241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.
    Zhou P; Lu Y; Zhang Y; Wang L
    Front Oncol; 2021; 11():661758. PubMed ID: 34277410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 5 and 8 in hepatocellular carcinoma.
    Kairaluoma V; Kemi N; Huhta H; Pohjanen VM; Helminen O
    APMIS; 2021 Aug; 129(8):470-479. PubMed ID: 33950532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in immunotherapy for hepatocellular carcinoma.
    Sangro B; Sarobe P; Hervás-Stubbs S; Melero I
    Nat Rev Gastroenterol Hepatol; 2021 Aug; 18(8):525-543. PubMed ID: 33850328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
    Pfister D; Núñez NG; Pinyol R; Govaere O; Pinter M; Szydlowska M; Gupta R; Qiu M; Deczkowska A; Weiner A; Müller F; Sinha A; Friebel E; Engleitner T; Lenggenhager D; Moncsek A; Heide D; Stirm K; Kosla J; Kotsiliti E; Leone V; Dudek M; Yousuf S; Inverso D; Singh I; Teijeiro A; Castet F; Montironi C; Haber PK; Tiniakos D; Bedossa P; Cockell S; Younes R; Vacca M; Marra F; Schattenberg JM; Allison M; Bugianesi E; Ratziu V; Pressiani T; D'Alessio A; Personeni N; Rimassa L; Daly AK; Scheiner B; Pomej K; Kirstein MM; Vogel A; Peck-Radosavljevic M; Hucke F; Finkelmeier F; Waidmann O; Trojan J; Schulze K; Wege H; Koch S; Weinmann A; Bueter M; Rössler F; Siebenhüner A; De Dosso S; Mallm JP; Umansky V; Jugold M; Luedde T; Schietinger A; Schirmacher P; Emu B; Augustin HG; Billeter A; Müller-Stich B; Kikuchi H; Duda DG; Kütting F; Waldschmidt DT; Ebert MP; Rahbari N; Mei HE; Schulz AR; Ringelhan M; Malek N; Spahn S; Bitzer M; Ruiz de Galarreta M; Lujambio A; Dufour JF; Marron TU; Kaseb A; Kudo M; Huang YH; Djouder N; Wolter K; Zender L; Marche PN; Decaens T; Pinato DJ; Rad R; Mertens JC; Weber A; Unger K; Meissner F; Roth S; Jilkova ZM; Claassen M; Anstee QM; Amit I; Knolle P; Becher B; Llovet JM; Heikenwalder M
    Nature; 2021 Apr; 592(7854):450-456. PubMed ID: 33762733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
    J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lncRNA HOTAIR knockdown suppresses gastric cancer cell biological activities.
    Chao P; Yongheng F; Jin Z; Yu Z; Shiyong Y; Kunxing Y; Yong M
    Food Sci Nutr; 2021 Jan; 9(1):123-134. PubMed ID: 33473276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.
    Ruf B; Heinrich B; Greten TF
    Cell Mol Immunol; 2021 Jan; 18(1):112-127. PubMed ID: 33235387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
    Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
    J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long-noncoding RNA MALAT1 regulates TGF-β/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells.
    Zhang J; Han C; Song K; Chen W; Ungerleider N; Yao L; Ma W; Wu T
    PLoS One; 2020; 15(1):e0228160. PubMed ID: 31995604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
    Vishnubalaji R; Shaath H; Elango R; Alajez NM
    Semin Cancer Biol; 2020 Oct; 65():65-79. PubMed ID: 31733291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma.
    Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X
    Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
    Li S; Zhang M; Zhang H; Hu K; Cai C; Wang J; Shi L; Ma P; Xu Y; Zheng P
    Clin Chim Acta; 2020 Feb; 501():252-257. PubMed ID: 31730812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-1
    Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Kong Y; Yang Z
    Cancer Immunol Immunother; 2019 Dec; 68(12):2041-2054. PubMed ID: 31720814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FAL1: A critical oncogenic long non-coding RNA in human cancers.
    Lv X; Li Y; Li Y; Li H; Zhou L; Wang B; Zhi Z; Tang W
    Life Sci; 2019 Nov; 236():116918. PubMed ID: 31610208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.
    Galle PR; Foerster F; Kudo M; Chan SL; Llovet JM; Qin S; Schelman WR; Chintharlapalli S; Abada PB; Sherman M; Zhu AX
    Liver Int; 2019 Dec; 39(12):2214-2229. PubMed ID: 31436873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA
    Su W; Guo C; Wang L; Wang Z; Yang X; Niu F; Tzou D; Yang X; Huang X; Wu J; Chen X; Zou L; Yang Z; Chen G
    Aging (Albany NY); 2019 Jul; 11(13):4587-4596. PubMed ID: 31291201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.